東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Chemotherapy and immunotherapy in ur...

Trabulsi, Edouard J.

Linked to FindBook

Google Book

Amazon

博客來

Chemotherapy and immunotherapy in urologic oncology = a guide for the advanced practice provider /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Chemotherapy and immunotherapy in urologic oncology/ edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi.
Reminder of title:	a guide for the advanced practice provider /
other author:	Trabulsi, Edouard J.
Published:	Cham :Springer International Publishing : : 2021.,
Description:	xiv, 307 p. :ill., digital ;24 cm.
[NT 15003449]:	Introduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer.
Contained By:	Springer Nature eBook
Subject:	Urinary organs - Cancer -
Online resource:	https://doi.org/10.1007/978-3-030-52021-2
ISBN:	9783030520212

Chemotherapy and immunotherapy in urologic oncology = a guide for the advanced practice provider /
Chemotherapy and immunotherapy in urologic oncologya guide for the advanced practice provider /[electronic resource] :edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi. - Cham :Springer International Publishing :2021. - xiv, 307 p. :ill., digital ;24 cm.

Introduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer.

This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book's chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects.

ISBN: 9783030520212

Standard No.: 10.1007/978-3-030-52021-2doiSubjects--Topical Terms:

2153575
Urinary organs
--Cancer

LC Class. No.: RC280.U74

Dewey Class. No.: 616.9946

Chemotherapy and immunotherapy in urologic oncology = a guide for the advanced practice provider /
LDR:03403nmm a2200325 a 4500 001 2235765
003 DE-He213
005 20200929021821.0
006 m d
007 cr nn 008maaau
008 211111s2021 sz s 0 eng d
020 $a 9783030520212 $q (electronic bk.)
020 $a 9783030520205 $q (paper)
024 7 $a 10.1007/978-3-030-52021-2 $2 doi
035 $a 978-3-030-52021-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.U74
072 7 $a MJS $2 bicssc
072 7 $a MED088000 $2 bisacsh
072 7 $a MJS $2 thema
082 0 4 $a 616.9946 $2 23
090 $a RC280.U74 $b C517 2021
245 0 0 $a Chemotherapy and immunotherapy in urologic oncology $h [electronic resource] : $b a guide for the advanced practice provider / $c edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xiv, 307 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer.
520 $a This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book's chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects.
650 0 $a Urinary organs $x Cancer $x Treatment. $3 2153575
650 1 4 $a Urology. $3 636586
650 2 4 $a Oncology. $3 751006
650 2 4 $a General Practice / Family Medicine. $3 893976
650 2 4 $a Primary Care Medicine. $3 894341
700 1 $a Trabulsi, Edouard J. $3 3486564
700 1 $a Lallas, Costas D. $3 3486565
700 1 $a Lizardi-Calvaresi, Anne E. $3 3486566
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-52021-2
950 $a Medicine (SpringerNature-11650)